000 | 01834 a2200505 4500 | ||
---|---|---|---|
005 | 20250518074850.0 | ||
264 | 0 | _c20200212 | |
008 | 202002s 0 0 eng d | ||
022 | _a1678-2674 | ||
024 | 7 |
_a10.1590/s0102-865020190110000005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKang, Liu | |
245 | 0 | 0 |
_aDexmedetomidine attenuates P2X4 and NLRP3 expression in the spine of rats with diabetic neuropathic pain. _h[electronic resource] |
260 |
_bActa cirurgica brasileira _c2019 |
||
300 |
_ae201901105 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article | ||
650 | 0 | 4 |
_aAdrenergic alpha-2 Receptor Agonists _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aDexmedetomidine _xpharmacology |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xdrug therapy |
650 | 0 | 4 |
_aDiabetic Neuropathies _xdrug therapy |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aInterleukin-1beta _xanalysis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicroscopy, Electron, Transmission |
650 | 0 | 4 |
_aNLR Family, Pyrin Domain-Containing 3 Protein _xanalysis |
650 | 0 | 4 |
_aNeural Conduction _xdrug effects |
650 | 0 | 4 | _aPain Threshold |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Purinergic P2X4 _xanalysis |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aSpine _xdrug effects |
650 | 0 | 4 | _aStreptozocin |
650 | 0 | 4 |
_aSural Nerve _xdrug effects |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aYayi, Huang | |
700 | 1 | _aFang, Zhou | |
700 | 1 | _aBo, Zhao | |
700 | 1 | _aZhongyuan, Xia | |
773 | 0 |
_tActa cirurgica brasileira _gvol. 34 _gno. 11 _gp. e201901105 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1590/s0102-865020190110000005 _zAvailable from publisher's website |
999 |
_c30442757 _d30442757 |